Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Jul 24, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Medicare Transaction Facilitator under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) and 2) Collection of Prescription Drug Event Data from Contracted Part D Providers for Payment. Comments are due by September 22, 2026.
Source: Federal Register
Jul 20, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA). Comments are due by September 18, 2026.
Source: Federal Register
Jul 16, 2026 - Notice of a proposed rule from the Centers for Medicare & Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; 3) the Ambulatory Specialty Model; 4) updates to drugs and biological products paid under Part B; 5) Medicare Shared Savings Program requirements; 6) updates to the Quality Payment Program; 7) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 8) updates to the Ambulance Fee Schedule regulations; 9) codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2026 provisions; 10) updates to Clinical Laboratory Fee Schedule regulations; and 11) updates to the Medicare Promoting Interoperability Program. Comments are due on September 14, 2026.
Source: Federal Register
Jul 14, 2026 - The Department of Health and Human Services is seeking comments on training and care delivery models to ensure safe and effective use of psychedelic drugs. Questions for consideration include training regarding patient eligibility, drug administration, and post-administration follow up; access for Federally Qualified Health Centers, Certified Community Behavioral Health Clinics, and Rural Health Clinics; and technologies that allow for expanded access while maintaining patient safety. Comments are due August 13, 2026.
Source: Federal Register
Jul 2, 2026 - Notice from the U.S. Department of Health and Human Services (HHS) terminating the March 27, 2020, declaration authorizing the emergency use of drugs and biological products during the COVID-19 pandemic. On June 29, 2026, the HHS Secretary determined that the circumstances no longer exist justifying this authorization of emergency use of drugs and biological products. The termination of the declaration is effective June 29, 2027.
Source: Federal Register
Jul 2, 2026 - Notice from the U.S. Department of Health and Human Services (HHS) terminating three declarations that authorized the emergency use of in vitro diagnostics for detection and/or diagnosis of SARS-CoV-2; personal respiratory protective devices during the COVID-19 outbreak; and medical devices, including alternative products used as medical devices. On June 29, 2026, the HHS Secretary determined that the circumstances no longer exist justifying the emergency use of these medical devices. These declarations are terminated effective December 26, 2026.
Source: Federal Register
Jul 2, 2026 - Describes a pilot program using an at-home prescription drug dispensing unit to help rural Minnesota residents with mobility issues remain in their homes in spite of healthcare access challenges. The initiative was started following a community health needs assessment showing almost 50% of residents have difficulty accessing healthcare. The initiative is expanding to more communities.
Source: KAAL
Jun 29, 2026 - Describes proposed legislation that makes changes to the 340B Drug Pricing Program and requests feedback on the proposal. Comments are due by August 28, 2026.
Source: U.S. Senate Committee on Health, Education, Labor, and Pensions
Jun 22, 2026 - Notice from the Health Resources and Services Administration (HRSA) correcting the total number of responses listed in the June 15, 2026, notice.
Source: Federal Register
Jun 22, 2026 - Offers an interview with an independent pharmacy owner and the president of the Kansas Pharmacists Association. Discusses clinical services, sustainability, and recognizing community needs.
Source: Pharmacy Times